Gan & Lee partners with IDF to expand its diabetes treatment portfolio

By Nikita Chaurasia  | Date: 2021-02-23

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

China-based leading pharmaceutical organization Gan & Lee Pharmaceuticals Co. Ltd. has announced to have signed a strategic collaboration with the International Diabetes Federation (IDF) to bolster its efforts towards promoting the prevention and care of diabetes across the globe.

For the uninitiated, the International Diabetes Federation is an umbrella organization that comprises around 230 national diabetes associations across more than 160 territories and countries. The group represents the interests of the growing population of diabetics as well as those at risk.

The partnership between the two organizations will open doors that will bolster future initiatives such as medical education by leveraging the global reach of IDF School of Diabetes. Gan & Lee Pharmaceuticals also intends on becoming a founding partner for the launch of the IDF WeChat platform in China, as cited by credible sources.

CEO of Gan & Lee Pharmaceuticals, Kai Du was reported saying that the joint venture with IDF will assist the company in reinforcing its global outreach and advocacy programs aimed at improving the lives of individuals affected by diabetes.

Expressing his enthusiasm towards the partnership, Prof. Andrew Boulton, President of IDF commented that the association looks forward to collectively offering affordable and uninterrupted care as well as education for diabetic patients across the globe.

Acknowledging the multidimensional nature of diabetes care, Gan & Lee claim to understand the significance of supporting advocacy initiatives and online educational resources. Moving forward, the company will be working towards offering cost-efficient, intensive care and education regarding diabetes, sources confirmed.

About Gan & Lee Pharmaceuticals

Gan & Lee Pharmaceuticals is a Beijing-headquartered organization that primarily focuses on the manufacture and distribution of pharmaceutical products. The company’s product portfolio includes synthetic human insulins, insulin glargine injections, insulin materials, and medical equipment.

Source credits –

https://www.prnewswire.com/in/news-releases/gan-amp-lee-announces-new-partnership-with-international-diabetes-federation-818317920.html#:~:text=BEIJING%20and%20BRIDGEWATER%2C%20N.J.%2C%20Feb,aims%20to%20support%20their%20global

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

L&T Technology Services partners with Qualcomm to amplify 5G adoption

L&T Technology Services partners with Qualcomm to amplify 5G adoption

By Nikita Chaurasia

L&T Technology Services Limited has recently announced that it is teaming up with Qualcomm Technologies, Inc., the world’s leading wireless technology innovator. With the latest collaboration, the firm plans to offer end-to-end solutions...

PNAS, Straive partner to deliver end-to-end content production services

PNAS, Straive partner to deliver end-to-end content production services

By Nikita Chaurasia

Renowned U.S.-based nonprofit and non-governmental organization, NAS (National Academy of Sciences), has reportedly collaborated with Straive, one of the leading technology-driven solutions providers for Content, EdTech, and Data. With this acquis...

Japan pushes innovations in 'deep tech' sector with solar cell technology

Japan pushes innovations in 'deep tech' sector with solar cell technology

By Nikita Chaurasia

Amid the most promising next-generation solar cell technology innovations, Enecoat Technologies, a provider of materials development services in Japan, is reportedly developing perovskite. Following its completion, the Kyoto-located start-up expec...

GIC to acquire majority shares in opulent Sani/Ikos properties

GIC to acquire majority shares in opulent Sani/Ikos properties

By Nikita Chaurasia

Singapore's sovereign wealth fund, GIC has agreed to pay around $2.2 billion to buy a majority stake in Sani/Ikos Group, a Mediterranean luxury resort operator, marking the largest transaction in the European resort market since the Covid-19 pand...

Excelra, Patcore partner to offer enhanced digital insights to customers

Excelra, Patcore partner to offer enhanced digital insights to customers

By Nikita Chaurasia

Excelra, a data and analytics solutions provider, has recently announced its partnership with Patcore, Inc., to provide better access to its analytics products and scientific data for customers in Japan. For the unversed, Excelra is one of the top...